Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SARS-CoV2 (COVID-19) Diagnosis in Human Saliva by MALDI-TOF MS Profiling

NCT04460638 is registered in ClinicalTrials.gov with Direction Centrale du Service de Santé des Armées as lead sponsor.

NCT NCT04460638
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04460638 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SARS-CoV2 (COVID-19) Diagnosis in Human Saliva by MALDI-TOF MS Profiling
Lead sponsor
Direction Centrale du Service de Santé des Armées
Phase
Observational
Overall status
Completed
Start date
July 23, 2020
Completion date
August 13, 2021
Enrollment
779 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov 2